Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption
Strong evidence of lung cancer screening’s effectiveness in mortality reduction, as demonstrated in the National Lung Screening Trial (NLST) in the US and the Dutch–Belgian Randomized Lung Cancer Screening Trial (NELSON), has prompted countries to implement formal lung cancer screening programs. How...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-11-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1264342/full |
| _version_ | 1797629698850684928 |
|---|---|
| author | Charlotte Poon Tim Wilsdon Iqra Sarwar Alexander Roediger Megan Yuan |
| author_facet | Charlotte Poon Tim Wilsdon Iqra Sarwar Alexander Roediger Megan Yuan |
| author_sort | Charlotte Poon |
| collection | DOAJ |
| description | Strong evidence of lung cancer screening’s effectiveness in mortality reduction, as demonstrated in the National Lung Screening Trial (NLST) in the US and the Dutch–Belgian Randomized Lung Cancer Screening Trial (NELSON), has prompted countries to implement formal lung cancer screening programs. However, adoption rates remain largely low. This study aims to understand how lung cancer screening programs are currently performing. It also identifies the barriers and enablers contributing to adoption of lung cancer screening across 10 case study countries: Canada, China, Croatia, Japan, Poland, South Korea and the United States. Adoption rates vary significantly across studied countries. We find five main factors impacting adoption: (1) political prioritization of lung cancer (2) financial incentives/cost sharing and hidden ancillary costs (3) infrastructure to support provision of screening services (4) awareness around lung cancer screening and risk factors and (5) cultural views and stigma around lung cancer. Although these factors have application across the countries, the weighting of each factor on driving or hindering adoption varies by country. The five areas set out by this research should be factored into policy making and implementation to maximize effectiveness and outreach of lung cancer screening programs. |
| first_indexed | 2024-03-11T10:56:50Z |
| format | Article |
| id | doaj.art-014cabf56e9a4a8cb91c06f5f2637a0b |
| institution | Directory Open Access Journal |
| issn | 2296-2565 |
| language | English |
| last_indexed | 2024-03-11T10:56:50Z |
| publishDate | 2023-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj.art-014cabf56e9a4a8cb91c06f5f2637a0b2023-11-13T04:25:34ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-11-011110.3389/fpubh.2023.12643421264342Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoptionCharlotte Poon0Tim Wilsdon1Iqra Sarwar2Alexander Roediger3Megan Yuan4Charles River Associates, London, United KingdomCharles River Associates, London, United KingdomCharles River Associates, London, United KingdomMSD International Business GmbH, Kriens, SwitzerlandMerck & Co., Inc., Kenilworth, NJ, United StatesStrong evidence of lung cancer screening’s effectiveness in mortality reduction, as demonstrated in the National Lung Screening Trial (NLST) in the US and the Dutch–Belgian Randomized Lung Cancer Screening Trial (NELSON), has prompted countries to implement formal lung cancer screening programs. However, adoption rates remain largely low. This study aims to understand how lung cancer screening programs are currently performing. It also identifies the barriers and enablers contributing to adoption of lung cancer screening across 10 case study countries: Canada, China, Croatia, Japan, Poland, South Korea and the United States. Adoption rates vary significantly across studied countries. We find five main factors impacting adoption: (1) political prioritization of lung cancer (2) financial incentives/cost sharing and hidden ancillary costs (3) infrastructure to support provision of screening services (4) awareness around lung cancer screening and risk factors and (5) cultural views and stigma around lung cancer. Although these factors have application across the countries, the weighting of each factor on driving or hindering adoption varies by country. The five areas set out by this research should be factored into policy making and implementation to maximize effectiveness and outreach of lung cancer screening programs.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1264342/fulllung cancerscreeningearly detectionadoptioncountry analysis |
| spellingShingle | Charlotte Poon Tim Wilsdon Iqra Sarwar Alexander Roediger Megan Yuan Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption Frontiers in Public Health lung cancer screening early detection adoption country analysis |
| title | Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption |
| title_full | Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption |
| title_fullStr | Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption |
| title_full_unstemmed | Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption |
| title_short | Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption |
| title_sort | why is the screening rate in lung cancer still low a seven country analysis of the factors affecting adoption |
| topic | lung cancer screening early detection adoption country analysis |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1264342/full |
| work_keys_str_mv | AT charlottepoon whyisthescreeningrateinlungcancerstilllowasevencountryanalysisofthefactorsaffectingadoption AT timwilsdon whyisthescreeningrateinlungcancerstilllowasevencountryanalysisofthefactorsaffectingadoption AT iqrasarwar whyisthescreeningrateinlungcancerstilllowasevencountryanalysisofthefactorsaffectingadoption AT alexanderroediger whyisthescreeningrateinlungcancerstilllowasevencountryanalysisofthefactorsaffectingadoption AT meganyuan whyisthescreeningrateinlungcancerstilllowasevencountryanalysisofthefactorsaffectingadoption |